Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Drug Manufacturers - Specialty & Generic Industry — Last 7 Days

Extreme outlier transactions (>3σ) are excluded.Show All Data
RatioAll Sells
Daily Buy & Sell Volume

Evolus, Inc. (EOLS)

Avelar Rui — See Remarks
Mar 20, 2026
Sale
Shares
3,119
Price
$4.75
Total Value
$14.82K
Shares Held After
427,423
% of Holdings
0.7%

Evolus, Inc. (EOLS)

MOATAZEDI DAVID — Director
Mar 20, 2026
Sale
Shares
13,669
Price
$4.75
Total Value
$64.93K
Shares Held After
604,700
% of Holdings
2.2%
Mar 19, 2026
Sale
Shares
124
Price
$53.24
Total Value
$6.60K
Shares Held After
73,320
% of Holdings
0.2%
Mar 19, 2026
Sale
Shares
4,977
Price
$52.79
Total Value
$262.72K
Shares Held After
73,444
% of Holdings
6.3%
Mar 19, 2026
Sale
Shares
1,939
Price
$51.78
Total Value
$100.41K
Shares Held After
78,421
% of Holdings
2.4%

COLLEGIUM PHARMACEUTICAL, INC (COLL)

Dieter David — EVP & General Counsel
Mar 18, 2026
Sale
Shares
13,976
Price
$34.92
Total Value
$488.10K
Shares Held After
77,071
% of Holdings
15.4%
Mar 18, 2026
Sale
Shares
2,651
Price
$53.64
Total Value
$142.21K
Shares Held After
80,360
% of Holdings
3.2%
Mar 18, 2026
Sale
Shares
3,598
Price
$53.03
Total Value
$190.82K
Shares Held After
83,011
% of Holdings
4.2%
Mar 18, 2026
Sale
Shares
4,311
Price
$51.80
Total Value
$223.30K
Shares Held After
86,609
% of Holdings
4.7%
Mar 18, 2026
Sale
Shares
412
Price
$50.48
Total Value
$20.80K
Shares Held After
17,044
% of Holdings
2.4%
Mar 18, 2026
Sale
Shares
6,838
Price
$49.55
Total Value
$338.82K
Shares Held After
17,456
% of Holdings
28.1%
Mar 17, 2026
Sale
Shares
5,280
Price
$51.66
Total Value
$272.76K
Shares Held After
90,920
% of Holdings
5.5%
Mar 17, 2026
Sale
Shares
500
Price
$21.81
Total Value
$10.90K
Shares Held After
20,136
% of Holdings
2.4%

Pacira BioSciences, Inc. (PCRX)

SLONIN JONATHAN — Chief Medical Officer
Mar 17, 2026
Sale
Shares
3,261
Price
$22.82
Total Value
$74.42K
Shares Held After
223,640
% of Holdings
1.4%
Mar 17, 2026
Sale
Shares
62,102
Price
$30.14
Total Value
$1.87M
Shares Held After
224,940
% of Holdings
21.6%

Evolus, Inc. (EOLS)

MOATAZEDI DAVID — Director
Mar 17, 2026
Sale
Shares
116,720
Price
$4.89
Total Value
$570.56K
Shares Held After
618,369
% of Holdings
15.9%

Evolus, Inc. (EOLS)

Avelar Rui — Chief Medical Officer and Head of Research & Development
Mar 17, 2026
Sale
Shares
29,996
Price
$4.89
Total Value
$146.63K
Shares Held After
430,542
% of Holdings
6.5%
Mar 17, 2026
Sale
Shares
22,290
Price
$50.73
Total Value
$1.13M
Shares Held After
17,044
% of Holdings
56.7%
Mar 17, 2026
Sale
Shares
27,710
Price
$49.95
Total Value
$1.38M
Shares Held After
39,334
% of Holdings
41.3%

Esperion Therapeutics, Inc. (ESPR)

Looker Benjamin — Chief Legal Officer
Mar 17, 2026
Sale
Shares
5,708
Price
$2.70
Total Value
$15.43K
Shares Held After
679,348
% of Holdings
0.8%

Esperion Therapeutics, Inc. (ESPR)

Halladay Benjamin — Chief Financial Officer
Mar 17, 2026
Sale
Shares
6,424
Price
$2.71
Total Value
$17.38K
Shares Held After
713,602
% of Holdings
0.9%
Mar 17, 2026
Sale
Shares
25,578
Price
$2.72
Total Value
$69.55K
Shares Held After
2,172,699
% of Holdings
1.2%
Mar 17, 2026
Sale
Shares
5,800
Price
$3.31
Total Value
$19.20K
Shares Held After
9,188,635
% of Holdings
0.1%
Mar 17, 2026
Sale
Shares
6,725,000
Price
$3.05
Total Value
$20.51M
Shares Held After
9,194,435
% of Holdings
42.2%
Mar 16, 2026
Sale
Shares
15,886
Price
$50.49
Total Value
$802.08K
Shares Held After
17,044
% of Holdings
48.2%
Mar 16, 2026
Sale
Shares
34,114
Price
$50.18
Total Value
$1.71M
Shares Held After
32,930
% of Holdings
50.9%
Version: v26.3.23